Clinical Trial Update: A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating DR-2031 for hot flashes in prostate cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DR-2031

Snippet

Sponsor: Duramed Research | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED